OverviewSuggest Edit

SIGA Technologies is a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats. The Company's lead product is TPOXX an orally administered antiviral drug that targets orthopoxvirus infections. While TPOXX is not yet approved as safe or effective by the U.S. Food & Drug Administration, it is a novel small-molecule drug that is being delivered to the U.S. Strategic National Stockpile under the Project BioShield Act of 2004.

TypePublic
HQNew York, US
Websitesiga.com
Employee Ratings2.4

Latest Updates

Employees (est.) (Feb 2019)41(+11%)
Revenue (FY, 2018)$477.1 M
Share Price (Jun 2019)$5.7 (+2%)

SIGA Technologies Office Locations

SIGA Technologies has offices in New York and Corvallis
New York, US (HQ)
660 Madison Ave #1700
Corvallis, US
4575 SW Research Way #110
Show all (2)

SIGA Technologies Financials and Metrics

SIGA Technologies Revenue

SIGA Technologies's revenue was reported to be $477.05 m in FY, 2018
USD

Revenue (Q1, 2019)

10.5m

EBIT (Q1, 2019)

2.2m

Market capitalization (10-Jun-2019)

459.7m

Closing stock price (10-Jun-2019)

5.7

Cash (31-Dec-2018)

100.7m

EV

434.6m
SIGA Technologies's current market capitalization is $459.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2018

Revenue

477.1m

General and administrative expense

13.2m12.5m10.6m13.7m12.9m

R&D expense

5.5m3.1m8.2m15.0m13.0m

Operating expense total

29.0m15.7m39.1m46.0m122.0m
Quarterly
USDQ3, 2013Q1, 2014Q3, 2018Q1, 2019

Revenue

471.1m10.5m

General and administrative expense

3.3m3.1m3.1m3.2m

R&D expense

2.3m549.4k3.7m4.0m

Operating expense total

7.9m6.2m102.2m8.3m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

91.3m99.7m112.7m28.7m19.9m100.7m

Accounts Receivable

982.0k491.6k3.7m3.2m1.8m2.0m

Inventories

20.5m19.0m12.4m26.2m3.0m2.9m

Current Assets

123.9m129.8m129.5m69.2m37.4m121.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

105.2m107.1m99.0m104.7m95.5m115.7m129.3m104.1m78.0m20.5m30.1m

Accounts Receivable

741.9k610.4k742.7k569.1k14.3m769.2k979.2k1.0m34.5m38.7m4.9m

Inventories

17.0m17.1m16.8m18.1m14.8m8.8m1.1m22.8m28.9m17.8m19.1m

Current Assets

143.9m133.3m129.7m124.1m131.3m133.2m139.5m128.5m143.6m86.6m65.2m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(17.2m)(265.5m)(39.5m)(39.7m)(36.2m)421.8m

Inventories

(2.9m)(236.1k)6.6m(13.8m)22.7m39.0

Cash From Operating Activities

58.4m14.2m11.1m(115.6m)(8.2m)68.9m

Cash From Investing Activities

(857.3k)(3.5m)3.9m1.2m(100.1k)78.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(12.8m)(3.4m)(6.3m)(246.4m)(13.7m)(19.4m)(10.4m)(20.0m)(29.3m)(8.6m)(16.1m)(25.9m)(11.6m)(18.6m)369.4m1.6m

Inventories

653.9k3.4m3.7m2.4m14.8m10.3m18.0m(10.4m)(16.5m)(5.3m)7.1m10.3m22.7m891.1k

Accounts Payable

1.6m680.9k3.6m4.8m3.2m8.5m9.9m2.9m2.3m

Cash From Operating Activities

72.8m16.6m8.5m18.6m13.9m27.6m(8.6m)(34.7m)(90.9m)1.6m2.5m(2.6m)(8.6m)(13.7m)72.5m9.4k
USDY, 2019

Revenue/Employee

255.1k
Show all financial metrics

SIGA Technologies Online and Social Media Presence

Embed Graph

SIGA Technologies News and Updates

SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019

NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, Chief Executive Officer, will be a speaker at the Non-Conventional Threats (NCT) Eu…

SIGA Technologies to Host Business Update Webcast on June 18, 2019

NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesda…

SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018

NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that that management will be ringing the Nasdaq Stock Market Opening Bell on Friday, September 14, 2018. The …

SIGA Technologies Awarded BARDA Contract for TPOXX®

- Contract Valued at Up to $629 Million –

SIGA Technologies Blogs

SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets

SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets Content Import Mon, 06/03/2019 - 07:31 SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Mar…

SIGA Announces Priority Review Voucher Transaction Totaling $80 Million

SIGA Announces Priority Review Voucher Transaction Totaling $80 Million Content Import Thu, 11/01/2018 - 07:33 SIGA Announces Priority Review Voucher Transaction Totaling $80 Million Nov 1, 2018 This release is a backfill from a News Wire Gener…

SIGA Technologies Frequently Asked Questions

  • How many employees does SIGA Technologies have?

    SIGA Technologies has 41 employees.

  • What is SIGA Technologies revenue?

    Latest SIGA Technologies annual revenue is $477.1 m.

  • What is SIGA Technologies revenue per employee?

    Latest SIGA Technologies revenue per employee is $11.6 m.

  • Who are SIGA Technologies competitors?

    Competitors of SIGA Technologies include Obsidian Therapeutics, Mymetics and Elite Pharmaceuticals.

  • Where is SIGA Technologies headquarters?

    SIGA Technologies headquarters is located at 660 Madison Ave #1700, New York.

  • Where are SIGA Technologies offices?

    SIGA Technologies has offices in New York and Corvallis.

  • How many offices does SIGA Technologies have?

    SIGA Technologies has 2 offices.